Cardea SOLO® ECG delivers rapid, accurate cardiac insights while allowing you to maximize reimbursement through global billing—without relying on third-party IDTFs.
Enhance patient care with an in-office solution and optimize revenue with a seamless, fully in-office system.
Request a free consultation today!
With Cardea SOLO, healthcare providers can download data and generate detailed reports in as little as 5 minutes. By bringing data processing in-office, Cardea SOLO makes chasing third-party vendors a thing of the past. This rapid turnaround time enables immediate diagnosis and treatment decisions, significantly reducing patient anxiety and potential health risks associated with delays.
Cardea SOLO supports global billing, allowing providers to retain the full reimbursement without sharing it with IDTF service centers.¹
The easy-to-wear and easy-to-use design of Cardea SOLO ensures high patient compliance and comfort, making it convenient for continuous monitoring. This user-friendly aspect is crucial for accurate data collection and patient satisfaction.
Our software has user-friendly views and offers convenient patient registration.
Bringing data processing in-office, Cardea SOLO makes chasing third-party vendors a thing of the past.
With access to your patient’s entire record by day, you can view every heartbeat and identify potential causes of symptoms.
Easily modify and customize reports to highlight critical data, ensuring that every report meets the exact standards of your clinical practice.
*Under Emergency Use Authorization during Covid-19 pandemic
*Study was conducted in 2020.
Cardea SOLO operates on a buy and bill model, which means you pay for the product initially and then seek reimbursement. While there is an upfront cost, the reimbursement typically more than offsets this, resulting in a significant profit margin for most customers. This profit margin is generally higher compared to other monitoring options such as service models or traditional Holter monitors.
Cardiac Insight provides several tools and programs to help you understand and maximize your reimbursement.
Can be worn up to 7 days, typically worn more than 1-2 days.
We offer a Holter Trade-In Program for healthcare providers who currently own their own Holter monitors. This program allows you to trade in your existing Holter devices for credit to purchase Cardea SOLO system.
To learn more and inquire about the trade-in program, please fill out the contact form. Our team will provide you with all the necessary details and assist you through the process.
Patients can continue their daily routine unless otherwise instructed by their healthcare provider. While being very simple to wear, Cardea SOLO requires your care and attention for a comfortable wear experience and the most useful information for their physician.
Cardea SOLO is water resistant, but does not support full submersion bathing or swimming. Avoid any activity that would cause excessive sweating.
If your Cardea SOLO monitor is found to be defective, we will replace it through our no-hassle RMA process. Please contact us to report the issue and initiate the replacement process.
We are committed to ensuring that you have reliable and functional devices for your patients.
Cardea SOLO has undergone rigorous testing and evaluation to ensure its reliability as an aid for clinicians in cardiac health assessment. Here are some key points:
FDA Clearance: Cardea SOLO passed stringent testing and met all requirements before receiving FDA clearance, demonstrating its safety and effectiveness.
Automated Process: The SOLO software automates processes such as noise filtering, report generation, and quality checks, ensuring consistency and accuracy in supporting clinical assessments. However, it is designed to assist clinicians, not replace them. The clinician remains responsible for ECG data collection, review, and interpretation.
ANSI/AAMI EC-57:2012(R2020) Standard: SOLO adheres to this standard, which includes beat-by-beat and run-by-run analysis of clinically relevant records to detect significant events, ensuring compliance with industry standards for ECG devices.
Proven Performance: With over 100,000 satisfied patients, Cardea SOLO has demonstrated its effectiveness and reliability as a tool that aids clinicians in providing high-quality care.
References Available: We can provide references upon request to further assure you of the software’s trustworthiness and its role in enhancing, not replacing, clinical judgment.
Cardea SOLO does not require pre-authorization for Medicare and most major commercial insurance payers, including BCBS, United Healthcare, Humana, Aetna, and Cigna, according to their written medical policies. Pre-certification is required by Medicaid for all products, and a few exceptions such as BCBS Federal, Molina, and CareFirst may still require pre-authorization. Overall, not having to pre-authorize or pre-certify Cardea SOLO saves office staff time, money, and reduces frustration, allowing for a smoother workflow and quicker patient care.
Meet Your Local Sales Rep!
Meet Our Dedicated Sales Team at Cardiac Insight! Fill out the form below, and one of our local sales managers will contact you to schedule your demo!
© 2024 Cardiac Insight, Inc. All rights reserved.
*Global vs Split Billing Scenarios For External Electrographic Recording (48 Hours Up To 7 Days), Nov. 2020, View Document
¹ When both the TC and PC are performed by the same entity and both the TC and the PC are furnished within the same Medicare Physician Fee Schedule (MPFS) payment locality.
